# Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

> **NCT00051688** · PHASE2 · TERMINATED · sponsor: **Chiron Corporation**

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** tezacitabine
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00051688
- **Lead sponsor:** Chiron Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** — (—)
- **Last updated:** 2006-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00051688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00051688, "Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00051688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*